Novel Catheter for the Diagnosis of Cardiovascular Disease

Project description

Innovation in cardiovascular disease diagnosis

Cardiovascular diseases account for 1.9 million deaths each year in the EU, posing one of the most frequent causes of death. The EU-funded Wirecath project aims to fund, clinically validate and provide an innovative medical device for diagnosing myocardial disease and narrowing in the coronary arteries. This technology offers high accuracy, improved cost-efficiency and greater manoeuvrability. It is founded on a sturdy non-complex base that uses novel positioning of pressure sensors that reduce the risk of hydrostatic errors that would usually lead to a diagnosis that misjudges the intensity of the disease.

Fields of science

• natural sciences › physical sciences › classical mechanics › fluid mechanics › fluid statics
• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases
• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › sensors

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

CAVIS TECHNOLOGIES AB

Net EU contribution

€ 50 000,00

Address

Kungsangsvagen 29a 3tr
753 23 Uppsala
Sweden

Region

Östra Sverige › Östra Mellansverige › Uppsala län

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00